Reston Wealth Management’s CVS Health CVS Stock Holding History

Reston Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-516	Closed	-$32.5K	–	148
2024 Q3	$32.5K	Buy	+516	New	+$30.1K	0.01%	162

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Reston Wealth Management's CVS Position: Q4 2024 in Review

Reston Wealth Management sold out of CVS Health (CVS) in Q4 2024, closing a stake of 516 shares — an estimated $32.5K sold.

Reston Wealth Management first reported a position in CVS in Q3 2024 and held it in 1 quarter. The position peaked at $32.5K in Q3 2024. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

Reston Wealth Management reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
Reston Wealth Management sold 516 CVS Health shares in Q4 2024, an estimated $32.5K.
Reston Wealth Management first reported a position in CVS Health in Q3 2024 and held it in 1 quarter.
Reston Wealth Management's CVS Health position peaked at $32.5K in Q3 2024.
1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Reston Wealth Management's 13F filing for Q4 2024, filed 23 Jan 2025.